During the past decade, Southern Vitreoretinal Assoc conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 10 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 10 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Vitreoretinal Assoc" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Kodiak Sciences Inc" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Apellis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Vitreoretinal Assoc" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Southern Vitreoretinal Assoc" are "Geographic Atrophy" (9 trials), "Diabetic Macular Edema" (5 trials), "Macular Degeneration" (3 trials), "Macular Degeneration, Age-Related" (3 trials) and "Neovascular Age-Related Macular Degeneration" (3 trials). Many other conditions were trialed in "Southern Vitreoretinal Assoc" in a lesser frequency.

Most popular intervention types in "Southern Vitreoretinal Assoc" are "Drug" (24 trials), "Other" (9 trials), "Procedure" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (10 trials), "Faricimab" (8 trials), "Aflibercept" (5 trials), "Ranibizumab" (4 trials) and "Lampalizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Southern Vitreoretinal Assoc" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Southern Vitreoretinal Assoc". undefined are not yet recruiting, 2 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Southern Vitreoretinal Assoc, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Southern Vitreoretinal Assoc, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".